Skip to main content
. 2021 Nov 17;19:467. doi: 10.1186/s12967-021-03133-5

Fig. 1.

Fig. 1

The inhibition of circNOLC1 represses breast cancer proliferation in vitro. A The levels of circNOLC1 were examined by qPCR in clinical breast cancer tissues (n = 30). BG The MDA-MB-231 and MDA-MB-231 cells were treated with circNOLC1 shRNAs. B and C The levels of circNOLC1 were validated by qPCR. D and E The cell viability was detected by CCK-8 assays. F and G The colony numbers of the cells were measured by colony formation assays. **P < 0.01, ***P < 0.001